INNOHEP 4 500 IU anti-Xa/0.45 ml, solution for injection in a pre-filled syringe 10 syringes of 0.45 ml
Active ingredients: Tinzaparin sodium
Commercialized according to BDPMDispensing in France: Prescription only
Solution for injection10 syringes of 0.45 mlsous-cutanée;voie extracorporelle autre
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- INNOHEP 4 500 UI anti-Xa/0,45 ml, solution injectable en seringue préremplie
- Pharmaceutical form
- solution injectable
- Route of administration
- sous-cutanée;voie extracorporelle autre
- Presentation description
- 10 seringue(s) préremplie(s) en verre de 0,45 ml
- Marketing authorisation holder
- DIFARMED (ESPAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 26 Nov 2025
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61422614CIP74900576CIP133400949005765Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| TINZAPARINE SODIQUEsolution | 4 500 Ul Anti-Xa · 0,45 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.